Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population
| Status: | Completed |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 55 - 88 |
| Updated: | 9/20/2018 |
| Start Date: | August 31, 2015 |
| End Date: | September 30, 2017 |
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases
The goal of the study is to provide a detailed description of treatments for CRPC (Castrate
Resistant Prostate Cancer) patients with bone metastases and the resource utilization and
costs associated with that diagnosis and subsequent treatments.
Resistant Prostate Cancer) patients with bone metastases and the resource utilization and
costs associated with that diagnosis and subsequent treatments.
Inclusion Criteria:
- First diagnosis for bone metastases for members diagnosed with prostate cancer found
in the claims data during the identification period
- Members age ≥ 55 to 89 years at index
- Medicare members with medical and pharmacy coverage; and
- Continuously enrolled during the pre- and post-index periods.
Exclusion Criteria:
- Member with diagnosis of any other cancer (excluding melanoma (ICD-9 172.x) and other
metastases (ICD-9 198.x)) before the index date; and
- Members age ≥ 89 years of age at index date
We found this trial at
1
site
Click here to add this to my saved trials
